- Home
- WHWK vs PCM Comparison
WHWK vs PCM Comparison
Compare WHWK & PCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHWK
- PCM
- Stock Information
- Founded
- WHWK 2007
- PCM 1993
- Country
- WHWK United States
- PCM United States
- Employees
- WHWK N/A
- PCM N/A
- Industry
- WHWK Biotechnology: Pharmaceutical Preparations
- PCM Trusts Except Educational Religious and Charitable
- Sector
- WHWK Health Care
- PCM Finance
- Exchange
- WHWK Nasdaq
- PCM Nasdaq
- Market Cap
- WHWK 82.4M
- PCM 79.1M
- IPO Year
- WHWK N/A
- PCM N/A
- Fundamental
- Price
- WHWK $1.82
- PCM $6.40
- Analyst Decision
- WHWK
- PCM
- Analyst Count
- WHWK 0
- PCM 0
- Target Price
- WHWK N/A
- PCM N/A
- AVG Volume (30 Days)
- WHWK 117.1K
- PCM 29.1K
- Earning Date
- WHWK 08-07-2025
- PCM 01-01-0001
- Dividend Yield
- WHWK N/A
- PCM 11.68%
- EPS Growth
- WHWK N/A
- PCM N/A
- EPS
- WHWK N/A
- PCM N/A
- Revenue
- WHWK $21,596,000.00
- PCM N/A
- Revenue This Year
- WHWK N/A
- PCM N/A
- Revenue Next Year
- WHWK N/A
- PCM N/A
- P/E Ratio
- WHWK N/A
- PCM N/A
- Revenue Growth
- WHWK N/A
- PCM N/A
- 52 Week Low
- WHWK $1.39
- PCM $6.88
- 52 Week High
- WHWK $3.81
- PCM $10.20
- Technical
- Relative Strength Index (RSI)
- WHWK 55.63
- PCM 63.99
- Support Level
- WHWK $1.76
- PCM $6.29
- Resistance Level
- WHWK $1.87
- PCM $6.33
- Average True Range (ATR)
- WHWK 0.07
- PCM 0.04
- MACD
- WHWK 0.02
- PCM 0.01
- Stochastic Oscillator
- WHWK 83.33
- PCM 79.41
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
About PCM PCM Fund Inc.
Pcm Fund Inc is a closed-end investment management company. Its investment objective is to seek current income as a primary focus and also capital appreciation. The Fund invests in agency-guaranteed mortgage-backed securities, private-label mortgage-backed securities, high-yield corporate debt securities, and commercial mortgage-backed securities.